These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17190248)

  • 1. [Diabetes and coronary heart disease frequently appear together. New guidelines regulate therapy and prevention].
    MMW Fortschr Med; 2006 Oct; 148(41):10-1. PubMed ID: 17190248
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular prevention in patients with diabetes and prediabetes.
    Anselmino M; Gohlke H; Mellbin L; Rydén L
    Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification and prevention of vascular risk. Significance of metformin].
    Isnard F; André P
    Journ Annu Diabetol Hotel Dieu; 1990; ():311-23. PubMed ID: 2195214
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes.
    Byrne CD
    Diabetes Obes Metab; 2004 Jul; 6(4):308-9. PubMed ID: 15171756
    [No Abstract]   [Full Text] [Related]  

  • 5. Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.
    Evans M; McEwan P; Peters JR; Currie CJ
    Diabetes Obes Metab; 2004 Jul; 6(4):299-307. PubMed ID: 15171755
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary prevention of type 2 diabetes].
    Hanefeld M
    Dtsch Med Wochenschr; 2002 May; 127(18):951-2. PubMed ID: 11987014
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
    [No Abstract]   [Full Text] [Related]  

  • 8. Framingham risk equations underestimate coronary heart disease risk in diabetes.
    Stevens RJ; Coleman RL; Holman RR
    Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes as a risk factor for coronary disease.
    Megarry S; Sapsford R; Hall A
    Practitioner; 1996 Jul; 240(1564):454-7. PubMed ID: 8801547
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes and the heart - revisited.
    Rydén L; Tschöpe D; Dörr R
    Herz; 2008 Apr; 33(3):169. PubMed ID: 18568309
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence suggests diabetes outcomes linked to homocysteine.
    Clement L
    Nephrol News Issues; 2003 Dec; 17(13):16-7. PubMed ID: 14694857
    [No Abstract]   [Full Text] [Related]  

  • 12. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
    Pöss J; Böhm M; Laufs U
    Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of coronary risk in Type II diabetes.
    Durrington P
    Clin Sci (Lond); 2001 Dec; 101(6):681-2. PubMed ID: 11724656
    [No Abstract]   [Full Text] [Related]  

  • 14. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
    Orford JL; Kinlay S; Fernandes J; Behrendt D; Ganz P; Selwyn AP
    J Lab Clin Med; 2001 Feb; 137(2):82-92. PubMed ID: 11174464
    [No Abstract]   [Full Text] [Related]  

  • 15. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.
    Paneni F
    Diab Vasc Dis Res; 2014 Jan; 11(1):5-10. PubMed ID: 24254974
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain.
    Orozco-Beltrán D; Gil-Guillen VF; Quirce F; Navarro-Perez J; Pineda M; Gomez-de-la-Cámara A; Pita S; Diez-Espino J; Mateos J; Merino J; Serrano-Rios M;
    Int J Clin Pract; 2007 Jun; 61(6):909-15. PubMed ID: 17504353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic macroangiopathy--therapy and prevention].
    Oikawa S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():146-50. PubMed ID: 12386986
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes: a new challenge in the prevention of coronary heart disease.
    Betteridge DJ
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):407. PubMed ID: 12497944
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiovascular diseases in diabetes].
    Sigal RJ
    Praxis (Bern 1994); 2001 Dec; 90(51-52):2283-92. PubMed ID: 11820171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.